Soleno Therapeutics Financial Health
How is Soleno Therapeutics's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: SLNO's short term assets ($24.9M) exceed its short term liabilities ($7.2M).
Long Term Liabilities: SLNO's short term assets ($24.9M) exceed its long term liabilities ($9.3M).
Debt to Equity History and Analysis
Debt Level: SLNO is debt free.
Reducing Debt: SLNO has not had any debt for past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SLNO has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: SLNO has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 18.2% each year.